Get started
Danaher CorporationDanaher CorporationDanaher Corporation

Danaher Corporation

No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsForecastsSeasonalsOptionsBondsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪152.39 B‬ USD
Dividend yield (indicated)
0.59%
Price to earnings Ratio (TTM)
43.49
Basic EPS (TTM)
5.08 USD
Net income (FY)
‪3.61 B‬ USD
Revenue (FY)
‪24.57 B‬ USD
Shares float
‪643.61 M‬
Beta (1Y)
1.00

About Danaher Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Rainer M. Blair
Website
danaher.com
Headquarters
Washington
Founded
1984
IPO date
Dec 10, 1969
Identifiers
3
ISIN US2358511028
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Check out other big names from the same industry as DHR.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


US235851AV4
Danaher Corporation 2.6% 01-OCT-2050
Yield to maturity
5.53%
Maturity date
Oct 1, 2050
D
US23291KAK1
DH Europe Finance II SARL 3.4% 15-NOV-2049
Yield to maturity
5.53%
Maturity date
Nov 15, 2049
DHR5314908
Danaher Corporation 2.8% 10-DEC-2051
Yield to maturity
5.46%
Maturity date
Dec 10, 2051
US235851AR3
Danaher Corporation 4.375% 15-SEP-2045
Yield to maturity
5.45%
Maturity date
Sep 15, 2045
D
US23291KAJ4
DH Europe Finance II SARL 3.25% 15-NOV-2039
Yield to maturity
5.12%
Maturity date
Nov 15, 2039
D
XS205114955
DH Europe Finance II SARL 1.8% 18-SEP-2049
Yield to maturity
4.35%
Maturity date
Sep 18, 2049
D
DHR4906001
DH Europe Finance II SARL 2.6% 15-NOV-2029
Yield to maturity
3.98%
Maturity date
Nov 15, 2029
D
XS205040617
DH Europe Finance II SARL 1.35% 18-SEP-2039
Yield to maturity
3.81%
Maturity date
Sep 18, 2039
XS205040609
DH Europe Finance II SARL 0.75% 18-SEP-2031
Yield to maturity
3.05%
Maturity date
Sep 18, 2031
XS214799537
Danaher Corporation 2.5% 30-MAR-2030
Yield to maturity
2.81%
Maturity date
Mar 30, 2030
D
XS205040480
DH Europe Finance II SARL 0.45% 18-MAR-2028
Yield to maturity
2.51%
Maturity date
Mar 18, 2028

See all DHR bonds 

ETFs holding the stock


VTI
Vanguard Total Stock Market ETF
Weight
0.22%
Market value
‪4.57 B‬
USD
VOO
Vanguard S&P 500 ETF
Weight
0.25%
Market value
‪3.64 B‬
USD
IVV
iShares Core S&P 500 ETF
Weight
0.23%
Market value
‪1.75 B‬
USD
SPY
State Street SPDR S&P 500 ETF
Weight
0.23%
Market value
‪1.62 B‬
USD
VTV
Vanguard Value ETF
Weight
0.61%
Market value
‪1.34 B‬
USD
XLV
State Street Health Care Select Sector SPDR ETF
Weight
2.42%
Market value
‪999.69 M‬
USD
VIG
Vanguard Dividend Appreciation ETF
Weight
0.66%
Market value
‪798.13 M‬
USD
VHT
Vanguard Health Care ETF
Weight
2.15%
Market value
‪445.14 M‬
USD
JEPI
JPMorgan Equity Premium Income ETF
Weight
0.86%
Market value
‪320.82 M‬
USD
MOAT
VanEck Morningstar Wide Moat ETF
Weight
2.51%
Market value
‪320.79 M‬
USD
GSPX
iShares Core S&P 500 UCITS ETF
Weight
0.23%
Market value
‪319.76 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of DHR is 216.76 USD — it has decreased by −1.72% in the past 24 hours. Watch Danaher Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Danaher Corporation stocks are traded under the ticker DHR.
DHR stock has fallen by −3.39% compared to the previous week, the month change is a −8.32% fall, over the last year Danaher Corporation has showed a 1.76% increase.
We've gathered analysts' opinions on Danaher Corporation future price: according to them, DHR price has a max estimate of 310.00 USD and a min estimate of 220.00 USD. Watch DHR chart and read a more detailed Danaher Corporation stock forecast: see what analysts think of Danaher Corporation and suggest that you do with its stocks.
DHR reached its all-time high on Sep 10, 2021 with the price of 296.02 USD, and its all-time low was 0.001312 USD and was reached on Jun 17, 1977. View more price dynamics on DHR chart.
See other stocks reaching their highest and lowest prices.
DHR stock is 1.86% volatile and has beta coefficient of 1.00. Track Danaher Corporation stock price on the chart and check out the list of the most volatile stocks — is Danaher Corporation there?
Today Danaher Corporation has the market capitalization of ‪152.40 B‬, it has decreased by −6.55% over the last week.
Yes, you can track Danaher Corporation financials in yearly and quarterly reports right on TradingView.
Danaher Corporation is going to release the next earnings report on Apr 28, 2026. Keep track of upcoming events with our Earnings Calendar.
DHR earnings for the last quarter are 2.23 USD per share, whereas the estimation was 2.16 USD resulting in a 3.11% surprise. The estimated earnings for the next quarter are 1.94 USD per share. See more details about Danaher Corporation earnings.
Danaher Corporation revenue for the last quarter amounts to ‪6.84 B‬ USD, despite the estimated figure of ‪6.81 B‬ USD. In the next quarter, revenue is expected to reach ‪6.00 B‬ USD.
DHR net income for the last quarter is ‪1.20 B‬ USD, while the quarter before that showed ‪908.00 M‬ USD of net income which accounts for 31.83% change. Track more Danaher Corporation financial stats to get the full picture.
Yes, DHR dividends are paid quarterly. The last dividend per share was 0.32 USD. As of today, Dividend Yield (TTM)% is 0.59%. Tracking Danaher Corporation dividends might help you take more informed decisions.
Danaher Corporation dividend yield was 0.56% in 2025, and payout ratio reached 25.35%. The year before the numbers were 0.47% and 20.42% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Danaher Corporation EBITDA is ‪7.68 B‬ USD, and current EBITDA margin is 29.05%. See more stats in Danaher Corporation financial statements.
Like other stocks, DHR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Danaher Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Danaher Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Danaher Corporation stock shows the neutral signal. See more of Danaher Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.